Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report

Jina Yun; Seok Jin Kim; Jong Ho Won; Chul Won Choi; Hyeon Seok Eom; Jin Seok Kim; Min Kyoung Kim; Jae Yong Kwak; Won Seog Kim; Cheolwon Suh

doi:10.1016/j.leukres.2010.02.010

Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report

Jina Yun
, Seok Jin Kim^*
, Jong Ho Won
, Chul Won Choi
, Hyeon Seok Eom
, Jin Seok Kim
, Min Kyoung Kim
, Jae Yong Kwak
, Won Seog Kim
, Cheolwon Suh

^*Corresponding author for this work

Department of Medicine

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

Abstract

Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.

Original language	English
Pages (from-to)	1175-1179
Number of pages	5
Journal	Leukemia Research
Volume	34
Issue number	9
DOIs	https://doi.org/10.1016/j.leukres.2010.02.010
Publication status	Published - 2010 Sept

Bibliographical note

Funding Information:
This study was supported by the Samsung Medical Center Clinical Research Development Program grant, #CRS-109-03-1 .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

B-cell
Chemotherapy
Lymphoma
Ovary
Prognosis
Rituximab
T-cell

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2010.02.010

Cite this

@article{7795d09ad51b45759ad945c5aa907e44,

title = "Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report",

abstract = "Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0\% and 59.3\%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.",

keywords = "B-cell, Chemotherapy, Lymphoma, Ovary, Prognosis, Rituximab, T-cell",

author = "Jina Yun and Kim, \{Seok Jin\} and Won, \{Jong Ho\} and Choi, \{Chul Won\} and Eom, \{Hyeon Seok\} and Kim, \{Jin Seok\} and Kim, \{Min Kyoung\} and Kwak, \{Jae Yong\} and Kim, \{Won Seog\} and Cheolwon Suh",

note = "Funding Information: This study was supported by the Samsung Medical Center Clinical Research Development Program grant, \#CRS-109-03-1 .",

year = "2010",

month = sep,

doi = "10.1016/j.leukres.2010.02.010",

language = "English",

volume = "34",

pages = "1175--1179",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd",

number = "9",

}

TY - JOUR

T1 - Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma

T2 - A Consortium for Improving Survival of Lymphoma (CISL) report

AU - Yun, Jina

AU - Kim, Seok Jin

AU - Won, Jong Ho

AU - Choi, Chul Won

AU - Eom, Hyeon Seok

AU - Kim, Jin Seok

AU - Kim, Min Kyoung

AU - Kwak, Jae Yong

AU - Kim, Won Seog

AU - Suh, Cheolwon

N1 - Funding Information: This study was supported by the Samsung Medical Center Clinical Research Development Program grant, #CRS-109-03-1 .

PY - 2010/9

Y1 - 2010/9

N2 - Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.

AB - Fourteen patients had primary ovarian lymphoma, while eighteen patients had secondary ovarian involvement. There was no significant difference in survival rates between primary and secondary involvement with diffuse large B-cell lymphoma (DLBCL), the most common subtype. The 5-year overall survivals of primary and secondary involvement with DLBCL were 70.0% and 59.3%, respectively. The localized bilateral ovarian involvement showed poorer survival compared to stage III/IV patients with secondary ovarian involvement. Treatment outcomes of secondary ovarian involvement in non-Hodgkin's lymphoma were comparable to those of primary ovarian involvement, suggesting that ovarian involvement does not necessarily predict a worse prognosis for NHL patients.

KW - B-cell

KW - Chemotherapy

KW - Lymphoma

KW - Ovary

KW - Prognosis

KW - Rituximab

KW - T-cell

UR - https://www.scopus.com/pages/publications/77955281346

U2 - 10.1016/j.leukres.2010.02.010

DO - 10.1016/j.leukres.2010.02.010

M3 - Article

C2 - 20206997

AN - SCOPUS:77955281346

SN - 0145-2126

VL - 34

SP - 1175

EP - 1179

JO - Leukemia Research

JF - Leukemia Research

IS - 9

ER -

Clinical features and prognostic relevance of ovarian involvement in non-Hodgkin's lymphoma: A Consortium for Improving Survival of Lymphoma (CISL) report

Abstract

Bibliographical note

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this